4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-021783
Director sold 59,621 shares at an average $10.80 ($644,048)
From the SEC's structured data for this filing
Trades in this filing
Canaan IX L.P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-06-02 | Sale : show line 1 in the form | −41,193 | $10.79 | $444,472 | 4,422,734 | I |
| 2016-06-03 | Sale : show line 2 in the form | −18,428 | $10.83 | $199,575 | 4,404,306 | I |
| Open-market sales · 59,621 sh · avg $10.80 · $644,048 | ||||||
Loading xslF345X03/doc4.xml…